Home / health news / Regeneron Pharmaceuticals, Inc. (REGN) Position Reduced by State Treasurer State of Michigan quoting : Sports Perspectives
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

Regeneron Pharmaceuticals, Inc. (REGN) Position Reduced by State Treasurer State of Michigan quoting : Sports Perspectives

as mentioned in State Treasurer State of Michigan owned 0.10% of Regeneron Pharmaceuticals worth $43,901,000 as of its most recent SEC filing.
WARNING: “Regeneron Pharmaceuticals, Inc. (REGN) Position Reduced by State Treasurer State of Michigan” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives.
Regeneron Pharmaceuticals Company ProfileRegeneron Pharmaceuticals, Inc is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.
Receive News & Ratings for Regeneron Pharmaceuticals Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Regeneron Pharmaceuticals Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.
State Treasurer State of Michigan reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 5.1% during the third quarter, according to its most recent disclosure with the SEC.

Regeneron Pharmaceuticals, Inc. (REGN) Position Reduced by State Treasurer State of Michigan

as declared in CG Asset Management LLC’s holdings in Regeneron Pharmaceuticals were worth $3,779,000 at the end of the most recent reporting period.
COPYRIGHT VIOLATION NOTICE: “Regeneron Pharmaceuticals, Inc. (REGN) Shares Sold by CG Asset Management LLC” was posted by Community Financial News and is owned by of Community Financial News.
Regeneron Pharmaceuticals Company ProfileRegeneron Pharmaceuticals, Inc is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions.
Regeneron Pharmaceuticals makes up about 1.4% of CG Asset Management LLC’s investment portfolio, making the stock its 20th largest position.
The firm owned 9,401 shares of the biopharmaceutical company’s stock after selling 45 shares during the period.

as declared in

The Regeneron Pharmaceuticals, Inc. (REGN) Given New $598.00 Price Target at Royal Bank Of Canada

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) had its target price decreased by Royal Bank Of Canada from $626.00 to $598.00 in a report issued on Friday morning.
Piedmont Investment Advisors LLC bought a new position in Regeneron Pharmaceuticals during the third quarter valued at approximately $6,902,000.
Regeneron Pharmaceuticals has a 12 month low of $325.35 and a 12 month high of $511.31.
LPL Financial LLC bought a new position in Regeneron Pharmaceuticals during the third quarter valued at approximately $1,233,000.
Leerink Swann reissued a buy rating and set a $530.00 price objective on shares of Regeneron Pharmaceuticals in a report on Wednesday, September 21st.

about the details read more from here

This content may collect you by Luaren Colin

To follow all the new news about health

Check Also

picture.jpg

A new recommendation to reduce the number of shots for children of HPV vaccine

according to “This vaccine should have been introduced as a vaccine that will prevent cancer, …